Steven F. Cummings, Vice President of Business Development Munitions and Government, and Managing Director, Day & Zimmermann and Rheinmetall Join venture, RDZM, joined Day & Zimmermann in October of 2017.  Prior to joining DZMG, Steve was the President of Chemring Group US, Chemring Sensors and Electronic Systems, and their US board. In this capacity, Steve was responsible for Chemring’s wide range of critical and lifesaving chemical, biological, and Improvised Explosive Device (IED) detection systems including a number of US Government Acquisition Category II Programs of Record.  Prior to that position, Steve was the Chemring Group Vice President of Global Business Development and it’s Vice President of Business Development for North America responsible for customer relations and growing the business.

Prior to entering private industry, Mr. Cummings had a distinguished 28-year career in the US Army retiring at the rank of Colonel. Steve served in a number of significant Army leadership positions including Project Manager Close Combat Systems at PEO Ammunition, where he was responsible for procurement and management of more than 200 ammunition items and counter-IED equipment. He also personally led the training teams that were fielding that equipment in Afghanistan in 2011. During his final position in government as Project Director Joint Services, Mr. Cummings led the conventional ammunition demilitarization program for the Department of Defense and was responsible for the modernization of the Army’s Government Owned Contractor Operated (GOCO) ammunition production facilities.

Steve holds multiple educational degrees, including a Bachelor of Science from the US Military Academy at West Point, an MBA from Clemson University and a Master’s Degree in Strategic Studies from the US Army War College.  Mr. Cummings’ military awards include the Defense Superior Service Medal, two awards of the Legion of Merit, the Bronze Star for service in Afghanistan, and the Army Staff Badge. Mr. Cummings also serves on the Board of Advisors for Tworx, LLC and on the Board of Directors for the Greenrose Holding Corporation OTC (GNRS).